Albert Einstein College of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Albert Einstein College of Medicine (AECM) a subsidiary of Montefiore Medical Center is a healthcare service provider that offers educational services. The institute operates as a research institute for medical education, basic research and clinical investigation. It offers education programs such as graduate medical education, graduate program, masters in bioethics, master of public health, medical program, masters in clinical research and MSTP program, among others. AECM provides its courses through departments such as anatomy structural biology, anesthesiology, biochemistry, cardiovascular and thoracic surgery, cell biology, dentistry, development and molecular biology. The institute also operates through departments including emergency medicine, genetics, medicine, microbiology and immunology, molecular pharmacology, pediatrics, physiology and biophysics and radiation oncology. AECM is headquartered in Bronx, New York, the US.

Albert Einstein College of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 12
Cue Biopharma Enters into Research Collaboration with Albert Einstein College of Medicine 13
Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 14
Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 15
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 16
Licensing Agreements 17
Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 17
Cue Biopharma Amends License Agreement with Albert Einstein 18
Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 19
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 20
Albert Einstein College of Medicine - Key Competitors 22
Albert Einstein College of Medicine - Key Employees 23
Albert Einstein College of Medicine - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Government and Public Interest 25
Jun 03, 2018: TAILORx Trial Finds Most Women with Early Breast Cancer Do Not Benefit from Chemotherapy 25
May 14, 2018: Einstein and Montefiore Awarded $25 Million from the NIH to Continue Its Institute for Clinical and Translational Research 27
Nov 29, 2017: Einstein Receives $174 Million in Fiscal Year 2017 29
Nov 27, 2017: Increased Oral Pathogens and Decreased Bacterial Diversity Predict Precancerous Lesions of Stomach Cancer 30
Nov 14, 2017: Einstein researchers receive $6 million grant to untangle the genetic protections against Alzheimers disease 31
Nov 06, 2017: NIH Funds Research to Fight Alzheimers Disease with Anti-Inflammatory Diet 32
Oct 19, 2017: Study Shows How Nerves Drive Prostate Cancer 33
Oct 16, 2017: Einstein Researchers Share $9 Million Grant to Find Anti-Aging Therapies 34
Oct 16, 2017: Scripps Florida Scientists Share $9 Million Grant to Develop Therapies that Target the Aging Process 35
Oct 09, 2017: Novel Treatment Causes Cancer to Self-Destruct Without Affecting Healthy Cells 36
Oct 06, 2017: FDA awards 15 grants for clinical trials to stimulate product development for rare diseases 38
Aug 22, 2017: Einstein Researchers Awarded $3 Million for Longevity and Aging Studies 40
Aug 08, 2017: First Long-Term Study on Medical Marijuanas Impact on Opioid Use for Pain 41
Jul 12, 2017: Montefiore And Einstein Awarded $3.4 Million NIH Grant To Integrate Opioid And Tobacco Addiction Treatment 42
Jun 09, 2017: NIH Funds NYC Center for AIDS Research 43
Jan 20, 2017: South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics 44
Product News 45
Oct 25, 2018: Novel combination therapy promotes wound healing 45
Other Significant Developments 46
Aug 09, 2018: Ebola virus experts discover powerful, new approach for future therapeutics 46
May 30, 2018: Montefiore And Einstein Break Barriers With First Picture-Based Dementia Screening Tool 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List Of Tables


Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Albert Einstein College of Medicine, Deals By Therapy Area, 2012 to YTD 2018 9
Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 12
Cue Biopharma Enters into Research Collaboration with Albert Einstein College of Medicine 13
Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 14
Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 15
Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 16
Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 17
Cue Biopharma Amends License Agreement with Albert Einstein 18
Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 19
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 20
Albert Einstein College of Medicine, Key Competitors 22
Albert Einstein College of Medicine, Key Employees 23
Albert Einstein College of Medicine, Subsidiaries 24

List Of Figures


Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Aalberts Industries NV - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Aalberts Industries NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Aalberts Industries NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

Aalberts Industries NV - Mergers and Acquisitions (M&A), Partnerships and Alliances and Investment Report

Aalberts Industries NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines Aalberts Industries NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

Albert Einstein College of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Albert Einstein College of Medicine (AECM) a subsidiary of Montefiore Medical Center is a healthcare service provider that offers educational services. The institute operates as a research institute for medical

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available